London School of Hygiene & Tropical Medicine – Developmental Therapeutics Review – Q4 2010
Summary
Global Market Direct’s pharmaceuticals report, “London School of Hygiene & Tropical Medicine – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.
Scope
Reasons to buy
Summary
Global Market Direct’s pharmaceuticals report, “London School of Hygiene & Tropical Medicine – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.
Scope
- Review of therapeutics under development by London School of Hygiene & Tropical Medicine.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of London School of Hygiene & Tropical Medicine with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of London School of Hygiene & Tropical Medicine’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.
Reasons to buy
- Identify new drug targets and therapeutic classes in London School of Hygiene & Tropical Medicine’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
- Evaluate London School of Hygiene & Tropical Medicine’s position with total access to a detailed information on its therapeutic products development.
- Assess the growth potential of London School of Hygiene & Tropical Medicine in its therapy areas of focus.
- Exploit collaboration and partnership opportunities with London School of Hygiene & Tropical Medicine.
- Avoid Intellectual Property Rights related issues.
London School of Hygiene & Tropical Medicine Snapshot
London School of Hygiene & Tropical Medicine Overview
Key Information
Key Facts
London School of Hygiene & Tropical Medicine – Research and Development Overview
Key Therapeutic Areas
London School of Hygiene & Tropical Medicine – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
London School of Hygiene & Tropical Medicine – Pipeline Products Glance
London School of Hygiene & Tropical Medicine – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
London School of Hygiene & Tropical Medicine Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
London School of Hygiene & Tropical Medicine–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
London School of Hygiene & Tropical Medicine – Drug Profiles
20% DIETHYLTOLUAMIDE
Product Description
Mechanism of Action
R&D Progress
Amodiaquine + artesunate (AQ/AS)
Product Description
Mechanism of Action
R&D Progress
Ciclosporin + Prednisolone
Product Description
Mechanism of Action
R&D Progress
dihydroartemisinin (DHA) + piperaquine
Product Description
Mechanism of Action
R&D Progress
Sulfadoxine + Pyrimethamine + Artesunate
Product Description
Mechanism of Action
R&D Progress
sulfadoxine + pyrimethamine + piperaquine
Product Description
Mechanism of Action
R&D Progress
sulfadoxine pyrimethamine + piperaquine
Product Description
Mechanism of Action
R&D Progress
Sulfadoxine-Pyrimethamine + Artesunate
Product Description
Mechanism of Action
R&D Progress
sulfalene-pyrimethamine + amodiaquine
Product Description
Mechanism of Action
R&D Progress
Sulphadoxine + Pyrimethamine + Artesunate
Product Description
Mechanism of Action
R&D Progress
Sulphadoxine + Pyrimethamine + Primaquine
Product Description
Mechanism of Action
R&D Progress
Sulphadoxine-pyrimethamine + Primaquine
Product Description
Mechanism of Action
R&D Progress
Tranexamic Acid
Product Description
Mechanism of Action
R&D Progress
BCG
Product Description
Mechanism of Action
R&D Progress
Chloroquine + Artesunate
Product Description
Mechanism of Action
R&D Progress
Chloroquine + Primaquine
Product Description
Mechanism of Action
R&D Progress
Ciclosporin
Product Description
Mechanism of Action
R&D Progress
Sulfadoxine + Pyrimethamine + Amodiaquine
Product Description
Mechanism of Action
R&D Progress
London School of Hygiene & Tropical Medicine – Pipeline Analysis
London School of Hygiene & Tropical Medicine – Pipeline Products by Therapeutic Class
London School of Hygiene & Tropical Medicine Pipeline Products By Target
London School of Hygiene & Tropical Medicine – Pipeline Products by Route of Administration
London School of Hygiene & Tropical Medicine – Pipeline Products by Molecule Type
London School of Hygiene & Tropical Medicine - Dormant Projects
London School of Hygiene & Tropical Medicine - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Sulfadoxine + pyrimethamine + chloroquine (SP/CQ)
London School of Hygiene & Tropical Medicine – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
LIST OF TABLES
London School of Hygiene & Tropical Medicine – Pipeline by Therapy Area and Indication, 2010
London School of Hygiene & Tropical Medicine – Pipeline by Stage of Development, 2010
London School of Hygiene & Tropical Medicine – Monotherapy Products in Pipeline, 2010
London School of Hygiene & Tropical Medicine – Combination Treatment Modalities in Pipeline, 2010
London School of Hygiene & Tropical Medicine – Phase III, 2010
London School of Hygiene & Tropical Medicine - Phase II, 2010
London School of Hygiene & Tropical Medicine - Pipeline By Therapeutic Class, 2010
London School of Hygiene & Tropical Medicine - Pipeline By Target, 2010
London School of Hygiene & Tropical Medicine – Pipeline By Route of Administration, 2010
London School of Hygiene & Tropical Medicine – Pipeline By Molecule Type, 2010
London School of Hygiene & Tropical Medicine - Dormant Developmental Projects, 2010
London School of Hygiene & Tropical Medicine - Discontinued Pipeline Products, 2010 44
LIST OF FIGURES
London School of Hygiene & Tropical Medicine – Pipeline by Therapy Area and Indication, 2010
London School of Hygiene & Tropical Medicine – Pipeline by Stage of Development, 2010
London School of Hygiene & Tropical Medicine – Monotherapy Products in Pipeline, 2010
London School of Hygiene & Tropical Medicine – Combination Treatment Modalities in Pipeline, 2010
London School of Hygiene & Tropical Medicine – Pipeline By Therapeutic Class, 2010
London School of Hygiene & Tropical Medicine - Pipeline By Target, 2010
London School of Hygiene & Tropical Medicine – Pipeline By Route of Administration, 2010
London School of Hygiene & Tropical Medicine – Pipeline By Molecule Type, 2010 42
London School of Hygiene & Tropical Medicine Overview
Key Information
Key Facts
London School of Hygiene & Tropical Medicine – Research and Development Overview
Key Therapeutic Areas
London School of Hygiene & Tropical Medicine – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
London School of Hygiene & Tropical Medicine – Pipeline Products Glance
London School of Hygiene & Tropical Medicine – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
London School of Hygiene & Tropical Medicine Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
London School of Hygiene & Tropical Medicine–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
London School of Hygiene & Tropical Medicine – Drug Profiles
20% DIETHYLTOLUAMIDE
Product Description
Mechanism of Action
R&D Progress
Amodiaquine + artesunate (AQ/AS)
Product Description
Mechanism of Action
R&D Progress
Ciclosporin + Prednisolone
Product Description
Mechanism of Action
R&D Progress
dihydroartemisinin (DHA) + piperaquine
Product Description
Mechanism of Action
R&D Progress
Sulfadoxine + Pyrimethamine + Artesunate
Product Description
Mechanism of Action
R&D Progress
sulfadoxine + pyrimethamine + piperaquine
Product Description
Mechanism of Action
R&D Progress
sulfadoxine pyrimethamine + piperaquine
Product Description
Mechanism of Action
R&D Progress
Sulfadoxine-Pyrimethamine + Artesunate
Product Description
Mechanism of Action
R&D Progress
sulfalene-pyrimethamine + amodiaquine
Product Description
Mechanism of Action
R&D Progress
Sulphadoxine + Pyrimethamine + Artesunate
Product Description
Mechanism of Action
R&D Progress
Sulphadoxine + Pyrimethamine + Primaquine
Product Description
Mechanism of Action
R&D Progress
Sulphadoxine-pyrimethamine + Primaquine
Product Description
Mechanism of Action
R&D Progress
Tranexamic Acid
Product Description
Mechanism of Action
R&D Progress
BCG
Product Description
Mechanism of Action
R&D Progress
Chloroquine + Artesunate
Product Description
Mechanism of Action
R&D Progress
Chloroquine + Primaquine
Product Description
Mechanism of Action
R&D Progress
Ciclosporin
Product Description
Mechanism of Action
R&D Progress
Sulfadoxine + Pyrimethamine + Amodiaquine
Product Description
Mechanism of Action
R&D Progress
London School of Hygiene & Tropical Medicine – Pipeline Analysis
London School of Hygiene & Tropical Medicine – Pipeline Products by Therapeutic Class
London School of Hygiene & Tropical Medicine Pipeline Products By Target
London School of Hygiene & Tropical Medicine – Pipeline Products by Route of Administration
London School of Hygiene & Tropical Medicine – Pipeline Products by Molecule Type
London School of Hygiene & Tropical Medicine - Dormant Projects
London School of Hygiene & Tropical Medicine - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Sulfadoxine + pyrimethamine + chloroquine (SP/CQ)
London School of Hygiene & Tropical Medicine – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
LIST OF TABLES
London School of Hygiene & Tropical Medicine – Pipeline by Therapy Area and Indication, 2010
London School of Hygiene & Tropical Medicine – Pipeline by Stage of Development, 2010
London School of Hygiene & Tropical Medicine – Monotherapy Products in Pipeline, 2010
London School of Hygiene & Tropical Medicine – Combination Treatment Modalities in Pipeline, 2010
London School of Hygiene & Tropical Medicine – Phase III, 2010
London School of Hygiene & Tropical Medicine - Phase II, 2010
London School of Hygiene & Tropical Medicine - Pipeline By Therapeutic Class, 2010
London School of Hygiene & Tropical Medicine - Pipeline By Target, 2010
London School of Hygiene & Tropical Medicine – Pipeline By Route of Administration, 2010
London School of Hygiene & Tropical Medicine – Pipeline By Molecule Type, 2010
London School of Hygiene & Tropical Medicine - Dormant Developmental Projects, 2010
London School of Hygiene & Tropical Medicine - Discontinued Pipeline Products, 2010 44
LIST OF FIGURES
London School of Hygiene & Tropical Medicine – Pipeline by Therapy Area and Indication, 2010
London School of Hygiene & Tropical Medicine – Pipeline by Stage of Development, 2010
London School of Hygiene & Tropical Medicine – Monotherapy Products in Pipeline, 2010
London School of Hygiene & Tropical Medicine – Combination Treatment Modalities in Pipeline, 2010
London School of Hygiene & Tropical Medicine – Pipeline By Therapeutic Class, 2010
London School of Hygiene & Tropical Medicine - Pipeline By Target, 2010
London School of Hygiene & Tropical Medicine – Pipeline By Route of Administration, 2010
London School of Hygiene & Tropical Medicine – Pipeline By Molecule Type, 2010 42
